Tag Archives: 3M

Financial Daily Dose 7.29.2019 | Top Story: Pfizer and Mylan Join Forces to Create Generics Powerhouse

BY: Michael D. Reif | July 29, 2019

Drug giants Pfizer and Mylan have inked a deal that will merge the former’s off-patent drugs with the latter’s generics business, a tie-up that creates a mammoth global seller of lower-priced medicines – WSJ and Bloomberg and NYTimes Friday’s GDP report showed US economic growth slowing to 2.1% in Q2, as higher consumer spending helped … Continue reading